Skip to main content

Educational videos

Filter by

Clinical Evidence

Explore key clinical studies evaluating Enterra® Therapy in treating diabetic and idiopathic gastroparesis. These videos highlight significant improvements in nausea and vomiting symptoms, supported by clinical research.

A Multi-Disciplinary Approach Provides Optimism for Patients Living with Gastroparesis

0:59:50
Watch recording
IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?